Global Kainic Acid 麻豆原创 Research Report 2024

Publication ID:

PB501246868

Publication Date:

January 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Kainic acid, or kainate, is an acid that naturally occurs in some seaweed. Kainic acid is a potent neuroexcitatory amino acid agonist that acts by activating receptors for glutamate, the principal excitatory neurotransmitter in the central nervous system. Glutamate is produced by the cell's metabolic processes and there are four major classifications of glutamate receptors: NMDA receptors, AMPA receptors, kainate receptors, and the metabotropic glutamate receptors. Kainic acid is an agonist for kainate receptors, a type of ionotropic glutamate receptor. Kainate receptors likely control a sodium channel that produces excitatory postsynaptic potentials (EPSPs) when glutamate binds.
The global Kainic Acid market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Kainic acid is commonly injected into laboratory animal models to study the effects of experimental ablation. Kainic acid is a direct agonist of the glutamic kainate receptors and large doses of concentrated solutions produce immediate neuronal death by overstimulating neurons to death. Such damage and death of neurons is referred to as an excitotoxic lesion. Thus, in large, concentrated doses kainic acid can be considered a neurotoxin, and in small doses of dilute solution kainic acid will chemically stimulate neurons. In fact, kainate seems to regulate serotonergic activity in the vertebrate retina.
This report aims to provide a comprehensive presentation of the global market for Kainic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kainic Acid.
Report Scope
The Kainic Acid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kainic Acid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kainic Acid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
R&D Systems
Abcam
Bio-Techne
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
Glentham Life Sciences
Enzo Life Sciences
Segment by Type
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Segment by Application
Epilepsy Treatment
Neurological Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kainic Acid companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Kainic Acid 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Low Purity(Below 97%)
1.2.3 Purity(Above 97% and Below 99%)
1.2.4 High Purity(Above 99%)
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Kainic Acid 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Epilepsy Treatment
1.3.3 Neurological Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kainic Acid 麻豆原创 Perspective (2019-2030)
2.2 Kainic Acid Growth Trends by Region
2.2.1 Global Kainic Acid 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Kainic Acid Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Kainic Acid Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Kainic Acid 麻豆原创 Dynamics
2.3.1 Kainic Acid Industry Trends
2.3.2 Kainic Acid 麻豆原创 Drivers
2.3.3 Kainic Acid 麻豆原创 Challenges
2.3.4 Kainic Acid 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kainic Acid Players by Revenue
3.1.1 Global Top Kainic Acid Players by Revenue (2019-2024)
3.1.2 Global Kainic Acid Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Kainic Acid 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Kainic Acid Revenue
3.4 Global Kainic Acid 麻豆原创 Concentration Ratio
3.4.1 Global Kainic Acid 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kainic Acid Revenue in 2023
3.5 Kainic Acid Key Players Head office and Area Served
3.6 Key Players Kainic Acid Product Solution and Service
3.7 Date of Enter into Kainic Acid 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Kainic Acid Breakdown Data by Type
4.1 Global Kainic Acid Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Kainic Acid Forecasted 麻豆原创 Size by Type (2025-2030)
5 Kainic Acid Breakdown Data by Application
5.1 Global Kainic Acid Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Kainic Acid Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Kainic Acid 麻豆原创 Size (2019-2030)
6.2 North America Kainic Acid 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Kainic Acid 麻豆原创 Size by Country (2019-2024)
6.4 North America Kainic Acid 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kainic Acid 麻豆原创 Size (2019-2030)
7.2 Europe Kainic Acid 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Kainic Acid 麻豆原创 Size by Country (2019-2024)
7.4 Europe Kainic Acid 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kainic Acid 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Kainic Acid 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Kainic Acid 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Kainic Acid 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kainic Acid 麻豆原创 Size (2019-2030)
9.2 Latin America Kainic Acid 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Kainic Acid 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Kainic Acid 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kainic Acid 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Kainic Acid 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Kainic Acid 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Kainic Acid 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 R&D Systems
11.1.1 R&D Systems Company Detail
11.1.2 R&D Systems Business Overview
11.1.3 R&D Systems Kainic Acid Introduction
11.1.4 R&D Systems Revenue in Kainic Acid Business (2019-2024)
11.1.5 R&D Systems Recent Development
11.2 Abcam
11.2.1 Abcam Company Detail
11.2.2 Abcam Business Overview
11.2.3 Abcam Kainic Acid Introduction
11.2.4 Abcam Revenue in Kainic Acid Business (2019-2024)
11.2.5 Abcam Recent Development
11.3 Bio-Techne
11.3.1 Bio-Techne Company Detail
11.3.2 Bio-Techne Business Overview
11.3.3 Bio-Techne Kainic Acid Introduction
11.3.4 Bio-Techne Revenue in Kainic Acid Business (2019-2024)
11.3.5 Bio-Techne Recent Development
11.4 Stemgent
11.4.1 Stemgent Company Detail
11.4.2 Stemgent Business Overview
11.4.3 Stemgent Kainic Acid Introduction
11.4.4 Stemgent Revenue in Kainic Acid Business (2019-2024)
11.4.5 Stemgent Recent Development
11.5 Cayman Chemical
11.5.1 Cayman Chemical Company Detail
11.5.2 Cayman Chemical Business Overview
11.5.3 Cayman Chemical Kainic Acid Introduction
11.5.4 Cayman Chemical Revenue in Kainic Acid Business (2019-2024)
11.5.5 Cayman Chemical Recent Development
11.6 Santa Cruz Biotechnology
11.6.1 Santa Cruz Biotechnology Company Detail
11.6.2 Santa Cruz Biotechnology Business Overview
11.6.3 Santa Cruz Biotechnology Kainic Acid Introduction
11.6.4 Santa Cruz Biotechnology Revenue in Kainic Acid Business (2019-2024)
11.6.5 Santa Cruz Biotechnology Recent Development
11.7 STEMCELL Technologies
11.7.1 STEMCELL Technologies Company Detail
11.7.2 STEMCELL Technologies Business Overview
11.7.3 STEMCELL Technologies Kainic Acid Introduction
11.7.4 STEMCELL Technologies Revenue in Kainic Acid Business (2019-2024)
11.7.5 STEMCELL Technologies Recent Development
11.8 Glentham Life Sciences
11.8.1 Glentham Life Sciences Company Detail
11.8.2 Glentham Life Sciences Business Overview
11.8.3 Glentham Life Sciences Kainic Acid Introduction
11.8.4 Glentham Life Sciences Revenue in Kainic Acid Business (2019-2024)
11.8.5 Glentham Life Sciences Recent Development
11.9 Enzo Life Sciences
11.9.1 Enzo Life Sciences Company Detail
11.9.2 Enzo Life Sciences Business Overview
11.9.3 Enzo Life Sciences Kainic Acid Introduction
11.9.4 Enzo Life Sciences Revenue in Kainic Acid Business (2019-2024)
11.9.5 Enzo Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

R&D Systems
Abcam
Bio-Techne
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
Glentham Life Sciences
Enzo Life Sciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.